First Slide: The Population NPSG.03.04.01 applies to

Article NPSG.03.04.01 mainly applies individuals involved in administering or labeling of medicines used by or applied to patients during procedural practices, such as surgeons, clinical laboratory technicians, nurses and anesthetic providers (Chinn, 2014). Labeling is another crucial part in ensuring the patient’s and labeling everything from medication to medical devices can minimize errors and improve the overall health outcome. Medical reports show that error in medication through improper labeling has contributed to death of patients due to improper doses, inappropriate prescribed medication and drug interactions. Clinical laboratory technicians having been working to put photographs of medication on bottle labels so as to enable nurses and surgeons identify the correct dosage amounts during the procedural practices. The following diagram shows a healthcare provider demonstrating a well-labeled drug:

http://www.rightmedlabel.com/resources/

Second Slide: Other Individuals who can use the Information

Although this brochure will mainly benefit clinical staff involved in procedural practices, the information contained in it can also be useful to other individuals and institutions interested in understanding how to achieve patient safety (Chinn, 2014). They include and trainees for healthcare provision, healthcare scholars, and government agencies interested safety of patients and agencies and individuals involved in making drugs. Organizational systems work not just to group drugs according to their classes, but also depending on their dosage amounts. The measure is an important step in pharmaceutical manufacturing profession. The governments, trainees and healthcare scholar emphasize that drugs be labeled using colored labels for easier identification (Chinn, 2014).

Third Slide: Enhancing Patient Safety

Adhering to the labeling directive of article NPSG.03.04.01 will always enhance patient safety (Chinn, 2014). Some medicines may be almost similar, but correct labeling will help to notice differences between them. For example, some drugs have similar labels, names, or packaging can cause when medical professionals are prescribing drugs to patient or when supplying them as indicated in the following diagram:

Correctly Labeled Bottles

http://webmm.ahrq.gov/case.aspx?caseID=201

In addition to failing to achieve the curing objective, administering wrong medicine may cause significant harm on a patient. In this regard, administering the right medicine prevents such harm and enhances the ability of clinicians to achieve the curing objective of medicine administration (Chinn, 2014). As required in article NPSG.03.04.01, labeling ensures that the right medicine is administered to a patient, hence preventing harm that may occur because of wrong administration and enhancing the ability to achieve curing objective of drug administration. Error in medication can cause harm to the patients especially when they receive the wrong medicine or wrong strength of intended medicine. Depending on medicines being used, the side effects can be minor or catastrophic. As a result, where similarity is identified to be unacceptable risk, product labeling should be given an additional scrutiny so are to reduce, rather than increase, the risk of confusion. For instance, drugs such as Coumadin (warfarin) products and Coversyl (perindopril) have recently been highlighted to cause have to patients who have been exposed to wafarin because of their similarities. Due to the risks exposed by the similarity between such drugs, they have been significant enough to cause changes to the labeling of Coversyl (Chinn, 2014).

References

Chinn, S. (2014). Avoiding Medical Errors: Joint Commission’s 2013 National Patient Safety

Goals. Podiatry Management, 33(7), 127.